ADAMTS4 and gastric cancer: ADAMTS4 (HR = 1.39, P < 0.001), ADAMTS6 (HR = 1.75, P < 0.001), ADAMTS7 (HR = 1.43, P < 0.033), ADAMTS10 (HR = 1.45, P < 0.026), ADAMTS12 (HR = 1.41, P < 0.040), ADAMTS15 (HR = 1.49, P < 0.016), ADAMTS16 (HR = 1.42, P < 0.034), ADAMTS18 (HR = 1.59, P=0.005), and other molecules were found to be associated with the overall survival (OS) of patients with GC.